Beta-agonist overuse and delay in obtaining medical review in high risk asthma: a secondary analysis of data from a randomised controlled trial
Reliever inhaler overuse and delay in medical review in asthma In asthma, overuse of beta-agonist reliever medication and delay in seeking medical review in an exacerbation are linked to asthma deaths. Janine Pilcher at the Medical Research Institute of New Zealand, and co-workers, conducted a revie...
Guardado en:
Autores principales: | Janine Pilcher, Mitesh Patel, Alison Pritchard, Darmiga Thayabaran, Stefan Ebmeier, Dominick Shaw, Peter Black, Irene Braithwaite, Mark Weatherall, Richard Beasley |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c61a595ab85b4f22a0bae3704b80e50f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The prevalence and outcome of short-acting β2-agonists overuse in asthma patients in Taiwan
por: Cheng-Yi Wang, et al.
Publicado: (2021) -
The contribution of an asthma diagnostic consultation service in obtaining an accurate asthma diagnosis for primary care patients: results of a real-life study
por: R. M. E. Gillis, et al.
Publicado: (2017) -
The impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting β2-agonists in the United Kingdom: a cross-sectional analysis
por: Ian D. Pavord, et al.
Publicado: (2017) -
Child and caregiver experiences and perceptions of asthma self-management
por: Lauren Kelada, et al.
Publicado: (2021) -
The use of electronic alerts in primary care computer systems to identify the over-prescription of short-acting beta2-agonists in people with asthma: a protocol for a systematic review
por: Shauna McKibben, et al.
Publicado: (2017)